Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.70 -0.08 (-4.49%)
As of: Sep 10, 2026 · 3:58 PM EDT

Transcode Therapeutics (RNAZ) Amortizatization of Intangibles (2023 - 2025)

Transcode Therapeutics' (RNAZ) quarterly Amortizatization of Intangibles came in at $37731.0 in Q1 2025, down 65.54% on a YoY basis from $109483.0 in Q1 2024, and down 66.46% quarter-over-quarter from $112509.0 in Q4 2024.

Analysis

Transcode Therapeutics (RNAZ) Amortizatization of Intangibles (2023 - 2025) Analysis & Trends

Transcode Therapeutics (RNAZ) has reported Amortizatization of Intangibles for 3 consecutive years, with $37731.0 the latest figure, recorded in Q1 2025.

  • For the quarter ending Q1 2025, Amortizatization of Intangibles fell 65.54% year-over-year to $37731.0; the trailing twelve-month figure through Dec 2025 stood at $37731.0 (down 91.5% YoY), and the FY2025 full-year result was $37731.0, down 91.5% from the prior year.
  • Amortizatization of Intangibles eased to $37731.0 in Q1 2025 per RNAZ's latest filing, from $112509.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $112509.0 in Q4 2024 and bottomed at $37731.0 in Q1 2025.
  • Historically, Amortizatization of Intangibles has averaged $97217.4 across 3 years, with a median of $108518.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles jumped 55.17% in 2024, then sank 65.54% in 2025.
  • Over 3 years, Amortizatization of Intangibles stood at $108518.0 in 2023, then grew by 3.68% to $112509.0 in 2024, then plunged by 66.46% to $37731.0 in 2025.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $37731.0, $112509.0, and $111490.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 600.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 1.39 Mn
10 Transcode Therapeutics 1.63 Mn 1.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 37,731.00
Dec 31, 2024 112,509.00
Sep 30, 2024 111,490.00
Jun 30, 2024 110,481.00
Mar 31, 2024 109,483.00
Dec 31, 2023 108,518.00
Sep 30, 2023 107,565.00
Jun 30, 2023 106,621.00
Mar 31, 2023 70,559.00